Hong Kong’s AI drug discovery firm Insilico closes $60M Series D

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain …
( read original story …)

---